Loading organizations...
§ Venture Capital · Sandersville, GA, USA
Investment vehicle presumably funding early/growth-stage life sciences, biotech, and healthcare companies.
Advanced Biotechnologies Venture Fund operates as a venture capital firm, specializing in the life sciences sector. The firm focuses its investment activities on early-stage Canadian startups, primarily engaging in Series A funding rounds. Its strategy involves identifying and supporting companies that develop innovative solutions within biotechnology and medical devices.
Established in 2011, Advanced Biotechnologies Venture Fund commenced operations from Sandersville, United States. The firm's foundation was built on capitalizing on promising advancements in biotechnology, specifically aiming to foster growth in Canadian-based companies. This included strategic investments designed to propel scientific and medical innovation forward.
The firm's portfolio, notably including Zymeworks, demonstrates its commitment to nurturing enterprises in the life sciences. Advanced Biotechnologies Venture Fund seeks to support the development of groundbreaking technologies that address significant unmet needs, ultimately advancing healthcare solutions. Its vision involves enabling the commercialization of scientific breakthroughs within the biotechnology and medical device sectors.
Advanced Biotechnologies Venture Fund has 1 tracked investment across 1 company. The latest tracked deal is $8.1M Other Equity in Zymeworks in September 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 22, 2011 | Zymeworks | $8.1M Other Equity | Advanced Biotechnologies Venture Fund, Shermaine Tilley | — |